Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Chronic lymphocytic leukemia (CLL)
Trial Type:  Treatment
Treatment/Intervention:  allogeneic bone marrow transplantation, bone marrow ablation with stem cell support, high-dose chemotherapy, bone marrow transplantation, autologous bone marrow transplantation
Trial Phase:  Phase II, Phase III
Results 1-6 of 6 for your search:
Start Over
Risk-Adapted Therapy in Treating Young Patients with Mature B-Cell Lymphoma or Leukemia
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Age: 0 to 21
Trial IDs: SJBC3, NCI-2011-01251, NCI-2010-00129, NCT01046825
Alemtuzumab Before Donor Stem Cell Transplant in Treating Patients With Hematologic Diseases
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 70 and under
Trial IDs: HIMSUM, NCI-2012-00639, NCT00058825
Partially-Matched Donor Stem Cell Transplant in Treating Younger Patients with High-Risk Hematologic Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: Not specified
Trial IDs: SCT 0813, NCI-2015-00141, CMH 13H11, CMH SCT 0813, NCT02053545
Donor Peripheral Blood Stem Cell or Bone Marrow Transplant in Treating Patients With Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 55 and under
Trial IDs: MT1999-14, NCI-2010-02157, 1999LS060, UMN-1999LS060, UMN-MT1999-14, NCT00612716
HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
Status: Active
Phase: Phase II
Type: Treatment
Age: 15 to 70
Trial IDs: 15-MMUD, NCI-2016-01455, NCT02793544
Start Over